# Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

> clinical trial · VERIFIED · 2026-07-22

Status: RECRUITING · Sponsor: Fred Hutchinson Cancer Center · Condition: Acute Leukemia of Ambiguous Lineage

- Company: Fred Hutchinson Cancer Center
- Sector: Acute Leukemia of Ambiguous Lineage
- Primary source: https://clinicaltrials.gov/study/NCT06013423

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.
